Increased central venous pressure is provoked not by pulmonary-circulation defects but by mild cardiac-strains in patients after Fontan procedure.

Different hemodynamic profiles to exercise in COPD and IPF candidates to lung transplantation: role of the pulmonary arterial stiffness

High-density lipoprotein cholesterol level as a predictor of long-term vasoreactivity in patients with idiopathic pulmonary arterial hypertension

ACE gene subtypes and pulmonary hypertension among patients with chronic obstructive pulmonary disease

Mitochondrial permeability transition pore blocker prevents right ventricular mitochondrial damage in monocrtaline-induced pulmonary hypertension

Abnormalities in platelet volume and count as predictors of thrombosis and bleeding in patients with Eisenmenger syndrome

Peak oxygen consumption in chronic thromboembolic pulmonary vascular disease is determined predominately by cardiac reserve and not by dead space ventilation.

BMP2 induces DUSP1 in pulmonary artery smooth muscle cells

The selective rho kinase inhibitor trans-6-((4-aminocyclohexyl)amino)-5-fluoro-2-methoxynicotinamide ameliorates monocrotaline-induced pulmonary hypertension

National institutes of health model compared with pulmonary hypertension connection and French registry equations provides a more realistic nine-year survival estimates